Biopharmaceutical company Renovacor, Inc., on August 14 announced it had raised $11 million in Series A financing to further develop its gene therapy-based treatments for CVD.

Health officials in the Midwest have confirmed at least 22 cases of vaping-related lung injury this month, according to recent reports, and are in the process of investigating as many as 18 more.

Intensive blood pressure control resulted in fewer white matter brain lesions than standard BP control in a recent study of nearly 450 hypertensive patients, suggesting stricter hypertension management could have significant benefits for brain health.

Long-term exposure to ambient air pollutants—especially ozone—increase a person’s chance of developing emphysema, according to research published August 13 in JAMA.

Compared to on-pump CABG, off-pump surgery is associated with lower rates of revascularization and a significantly increased risk of all-cause death at three years, according to an analysis of the EXCEL trial.

Researchers on the International Space Station are leveraging the microgravity conditions within the ISS U.S. National Laboratory to study heart cells in ways we can’t on the ground.

Transport to the hospital via mobile stroke unit—as opposed to standard transit in an ambulance—saved stroke victims 10 minutes and up to 270 million neurons in a study out of the University of Texas Health Science Center at Houston.

A commonly prescribed drug used to treat attention-deficit/hyperactivity disorder (ADHD) disproportionately affects the development of children’s brains compared to adults with ADHD, according to a new study published in Radiology.